
Lilly’s EBGLYSS™ Achieves Skin Clearance and Itch Relief in Atopic Dermatitis Patients
Eli Lilly and Company has reported encouraging findings regarding its treatment EBGLYSS, showing significant improvements in skin condition and itch relief for patients suffering from moderate-to-severe atopic dermatitis (eczema) who had previously been treated with dupilumab. These results, stemming from…